UnknownNot applicableNCT05681949
Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards
Studying Adenocarcinoma of the liver and intrahepatic biliary tract
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Charite University, Berlin, Germany
- Principal Investigator
- Felix KrenzienCharite University, Berlin, Germany
- Intervention
- ADBoard(other)
- Enrollment
- 1200 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany
Collaborators
German Research Center for Artificial Intelligence
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05681949 on ClinicalTrials.govOther trials for Adenocarcinoma of the liver and intrahepatic biliary tract
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT05286814PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical CarcinomaNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGPHASE2NCT04941287Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract CancerNational Cancer Institute (NCI)
See all trials for Adenocarcinoma of the liver and intrahepatic biliary tract →